MedPath

上海衡山药业有限公司

Ownership
-
Established
1981-07-20
Employees
-
Market Cap
-
Website
www.hengshanpharm.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

120

NMPA:120

Drug Approvals

头孢拉定胶囊

Approval Number
国药准字H31021560
Approval Date
Jul 4, 2024
NMPA

诺氟沙星胶囊

Approval Number
国药准字H31021388
Approval Date
Jul 4, 2024
NMPA

辅酶Q10胶囊

Approval Number
国药准字H19999170
Approval Date
Jul 2, 2024
NMPA

头孢氨苄胶囊

Approval Number
国药准字H31021103
Approval Date
Jul 2, 2024
NMPA

Faropenem Sodium Capsules

Product Name
法罗培南钠胶囊
Approval Number
国药准字H20080160
Approval Date
Apr 25, 2023
NMPA

盐酸依普拉酮片

Approval Number
国药准字H31022362
Approval Date
Jul 2, 2020
NMPA

盐酸舍曲林片

Approval Number
国药准字H20051279
Approval Date
Jul 2, 2020
NMPA

头孢克肟胶囊

Approval Number
国药准字H20051650
Approval Date
Jul 2, 2020
NMPA

Famotidine Powder

Product Name
法莫替丁散
Approval Number
国药准字H10970254
Approval Date
May 26, 2020
NMPA

熊去氧胆酸片

Approval Number
国药准字H31021313
Approval Date
Apr 9, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 12
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.